As Partners CO.,LTD. (JP:160A)
:160A
Top Page
As Partners CO.,LTD.
(160A)
Select Model
Select Model
Rating:46Neutral
Price Target:
¥2,078.00
▼(-32.53% Downside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by weak financial quality (high leverage and volatile/negative 2025 free cash flow) and bearish technical conditions (below major moving averages with negative MACD). Valuation is also a headwind given the high P/E, with the dividend yield providing only modest support.
Positive Factors
Improved profitability / high ROE
ROE near 23% across 2024–2025 indicates the company is generating strong returns on its equity base. Over months this supports reinvestment capacity and shareholder returns potential, signaling operational improvement and management effectiveness despite a small equity cushion.
Negative Factors
Elevated leverage
Debt consistently more than twice equity creates a high structural leverage burden. That amplifies operational shocks, constrains flexibility for capital allocation, and raises refinancing and covenant risk if cash flows weaken, posing a sustained financial vulnerability.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved profitability / high ROE
ROE near 23% across 2024–2025 indicates the company is generating strong returns on its equity base. Over months this supports reinvestment capacity and shareholder returns potential, signaling operational improvement and management effectiveness despite a small equity cushion.
Read all positive factors
As Partners CO.,LTD. (160A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.76B
Dividend Yield2.19%
Average Volume (3M)33.94K
Price to Earnings (P/E)48.4
Beta (1Y)0.74
Revenue GrowthN/A
EPS GrowthN/A
CountryJP
Employees900
SectorIndustrials
Sector Strength72
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)13.26
Shares Outstanding3,587,400
10 Day Avg. Volume16,980
30 Day Avg. Volume33,940
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.58
Price to Sales (P/S)0.37
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)329.6
Revenue Forecast (FY)¥26.00B
As Partners CO.,LTD. Business Overview & Revenue Model
Company Description
AS Partners Co. Ltd. provides nursing care services. The company offers nursing care homes, daily living care services, short term residential care, and other services. It also develops and operates nursing homes, aging real estate, and provides c...
As Partners CO.,LTD. Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
48
Neutral
Cash Flow
38
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 17.92B | 17.15B | 12.78B | 11.52B |
| Gross Profit | 3.86B | 3.11B | 2.15B | 1.87B |
| EBITDA | 1.64B | 1.08B | 552.06M | 1.02B |
| Net Income | 956.66M | 563.57M | 229.71M | 484.94M |
Balance Sheet | ||||
| Total Assets | 21.41B | 15.95B | 14.75B | 11.82B |
| Cash, Cash Equivalents and Short-Term Investments | 6.86B | 5.71B | 4.02B | 3.86B |
| Total Debt | 9.31B | 5.66B | 6.49B | 5.13B |
| Total Liabilities | 17.24B | 13.57B | 12.88B | 10.13B |
| Stockholders Equity | 4.16B | 2.38B | 1.86B | 1.68B |
Cash Flow | ||||
| Free Cash Flow | -3.29B | 2.19B | -1.86B | -1.06B |
| Operating Cash Flow | 1.31B | 3.43B | -745.18M | -338.97M |
| Investing Cash Flow | -4.65B | -1.43B | -707.64M | 928.45M |
| Financing Cash Flow | 4.46B | -884.25M | 1.31B | -369.06M |
As Partners CO.,LTD. Technical Analysis
Negative
3080.00
Price Trends
2257.93
Negative
2351.46
Negative
2604.37
Negative
Market Momentum
-27.06
Negative
47.36
Neutral
74.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:160A, the sentiment is Negative. The current price of 3080 is above the 20-day moving average (MA) of 2146.63, above the 50-day MA of 2257.93, and above the 200-day MA of 2604.37, indicating a neutral trend. The MACD of -27.06 indicates Negative momentum. The RSI at 47.36 is Neutral, neither overbought nor oversold. The STOCH value of 74.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:160A.
As Partners CO.,LTD. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥2.83B | 27.02 | ― | 2.56% | -3.06% | -38.56% | |
72 Outperform | ¥43.70B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥5.89B | 23.20 | ― | 4.07% | 6.08% | 38.00% | |
46 Neutral | ¥7.76B | 48.43 | ― | 2.19% | ― | ― | |
45 Neutral | ¥6.41B | -88.53 | ― | 1.41% | 18.03% | -11.68% |
* Industrials Sector Average
JP:160A
As Partners CO.,LTD.
2,164.00
428.49
24.69%
JP:2373
Care Twentyone Corporation
436.00
61.14
16.31%
JP:2425
Care Service Co., Ltd.
747.00
-5.39
-0.72%
JP:6062
Charm Care Corporation
1,340.00
183.86
15.90%
JP:7061
Japan Hospice Holdings Inc.
761.00
-727.10
-48.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.